Product
Vorolanib
2 clinical trials
5 indications
Indication
Thymic CarcinomaIndication
Lung CancerIndication
Refractory Thoracic TumorsIndication
Small Cell Lung CancerIndication
Extensive-stage Small Cell Lung CancerClinical trial
Phase 1/2 Study to Evaluate the Safety and Preliminary Activity of Nivolumab in Combination With Vorolanib in Patients With Refractory Thoracic TumorsStatus: Active (not recruiting), Estimated PCD: 2024-02-21
Clinical trial
A Phase II Study of Maintenance Vorolanib and Atezolizumab in Patients With Extensive-stage SCLCStatus: Active (not recruiting), Estimated PCD: 2022-08-18